Promega
Stilla Technologies, Promega Ink Comarketing Deal for Digital PCR
The firms will combine Promega's Maxwell nucleic acid extraction systems and Stilla's six-color Naica digital PCR platform and create a workflow for different applications.
Promega, Henlius to Develop Microsatellite Instability CDx for Cancer Drug
The companies aim to develop the companion diagnostic for use with Henlius' investigational treatment for microsatellite instability-high solid tumors.
FDA Clears Promega Microsatellite Instability Test System
The OncoMate MSI Dx Analysis System is used to diagnose Lynch syndrome, a hereditary condition that increases cancer risk.
Promega to Develop MSI Assay as CDx for Incyte Endometrial Cancer Drug
Promega will develop its microsatellite instability assay as a companion diagnostic for Incyte's anti-PD-1 drug candidate retifanlimab in endometrial cancer.